Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1730

1.

Current Value Frameworks-What's New?

Willke RJ, Chapman RH, Seidman JJ, Schnipper LE, Gleason PP.

Value Health. 2019 Jun;22(6S):S7-S11. doi: 10.1016/j.jval.2019.04.1916. No abstract available.

PMID:
31200806
2.

Use of a Novel Enhanced DNA Vaccine Vector for Preclinical Virus Vaccine Investigation.

Chapman R, Rybicki EP.

Vaccines (Basel). 2019 Jun 13;7(2). pii: E50. doi: 10.3390/vaccines7020050. Review.

3.

New Cost-Effectiveness Methods to Determine Value-Based Prices for Potential Cures: What Are the Options?

Pearson SD, Ollendorf DA, Chapman RH.

Value Health. 2019 Jun;22(6):656-660. doi: 10.1016/j.jval.2019.01.012. Epub 2019 May 17.

PMID:
31198182
4.

The Adverse Impact of Unplanned Extubation in a Cohort of Critically Ill Neonates.

Kambestad KK, Huack A, Nair S, Chapman R, Chin S, Langga L, Mounger E, Guerrero E, Iyer NP.

Respir Care. 2019 May 28. pii: respcare.06721. doi: 10.4187/respcare.06721. [Epub ahead of print]

PMID:
31138734
5.

Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.

Lynch KD, Chapman RW, Keshav S, Montano-Loza AJ, Mason AL, Kremer AE, Vetter M, de Krijger M, Ponsioen CY, Trivedi P, Hirschfield G, Schramm C, Liu CH, Bowlus CL, Estes DJ, Pratt D, Hedin C, Bergquist A, de Vries AC, Janneke van der Woude C, Yu L, Assis DN, Boyer J, Ytting H, Hallibasic E, Trauner M, Marschall HU, Daretti LM, Marzioni M, Yimam KK, Perin N, Floreani A, Beretta-Piccoli BT, Rogers JK; International Primary Sclerosing Cholangitis Study Group (IPSCSG), Levy C.

Clin Gastroenterol Hepatol. 2019 May 14. pii: S1542-3565(19)30523-3. doi: 10.1016/j.cgh.2019.05.013. [Epub ahead of print]

6.

Photodissociation dynamics of CH3I probed via multiphoton ionisation photoelectron spectroscopy.

Warne EM, Downes-Ward B, Woodhouse J, Parkes MA, Bellshaw D, Springate E, Majchrzak P, Zhang Y, Karras G, Wyatt AS, Chapman RT, Kirrander A, Minns RS.

Phys Chem Chem Phys. 2019 Jun 7;21(21):11142-11149. doi: 10.1039/c9cp01477b. Epub 2019 May 16.

PMID:
31094379
7.

Comment on "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States".

McQueen RB, Whittington MD, Chapman RH, Kumar VM, Campbell JD.

Pharmacoeconomics. 2019 Jul;37(7):963-964. doi: 10.1007/s40273-019-00802-8. No abstract available.

PMID:
31044348
8.

Can We Develop Sustainable and Sharable Cost-Effectiveness Models for Value Assessment in the U.S. Health Care System?

Chapman RH, Kumar V.

J Manag Care Spec Pharm. 2019 May;25(5):521-524. doi: 10.18553/jmcp.2019.25.5.521.

9.

Screening duplex ultrasonography in neurosurgery patients does not correlate with a reduction in pulmonary embolism rate or decreased mortality.

Dickerson JC, Harriel KL, Dambrino RJ, Taylor LI, Rimes JA, Chapman RW, Desrosiers AS, Tullis JE, Washington CW.

J Neurosurg. 2019 Apr 26:1-9. doi: 10.3171/2018.12.JNS182800. [Epub ahead of print]

PMID:
31026839
10.

The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.

Lynch KD, Keshav S, Chapman RW.

Curr Hepatol Rep. 2019;18(1):115-126. doi: 10.1007/s11901-019-00456-2. Epub 2019 Mar 7. Review.

11.

Response to letter to the editor re 'The effect of inspiratory rise times on sputum movement during ventilator hyperinflation in a test lung model'.

Chapman RL.

Physiotherapy. 2019 Jun;105(2):295. doi: 10.1016/j.physio.2019.01.008. Epub 2019 Jan 22. No abstract available.

PMID:
31000367
12.

Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness Model.

Kumar VM, Agboola F, Synnott PG, Segel C, Webb M, Ollendorf DA, Banken R, Chapman RH.

Value Health. 2019 Apr;22(4):416-422. doi: 10.1016/j.jval.2018.12.005. Epub 2019 Mar 21.

PMID:
30975392
13.

Continuously monitoring shoulder motion after total shoulder arthroplasty: maximum elevation and time spent above 90° of elevation are critical metrics to monitor.

Chapman RM, Torchia MT, Bell JE, Van Citters DW.

J Shoulder Elbow Surg. 2019 Apr 4. pii: S1058-2746(19)30006-0. doi: 10.1016/j.jse.2019.01.003. [Epub ahead of print]

PMID:
30956145
14.

Polymer mediated transport of the Hsp90 inhibitor LB76, a polar cyclic peptide, produces an Hsp90 cellular phenotype.

Rahimi MN, Foster HG, Farazi SN, Chapman R, McAlpine SR.

Chem Commun (Camb). 2019 Apr 11;55(31):4515-4518. doi: 10.1039/c9cc00890j.

PMID:
30920570
15.

Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell Lymphoma.

Whittington MD, McQueen RB, Ollendorf DA, Kumar VM, Chapman RH, Tice JA, Pearson SD, Campbell JD.

JAMA Netw Open. 2019 Feb 1;2(2):e190035. doi: 10.1001/jamanetworkopen.2019.0035.

16.

Evolving role of magnetic resonance techniques in primary sclerosing cholangitis.

Selvaraj EA, Culver EL, Bungay H, Bailey A, Chapman RW, Pavlides M.

World J Gastroenterol. 2019 Feb 14;25(6):644-658. doi: 10.3748/wjg.v25.i6.644. Review.

17.

Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus.

van Diepen MT, Chapman R, Douglass N, Galant S, Moore PL, Margolin E, Ximba P, Morris L, Rybicki EP, Williamson AL.

J Virol. 2019 Apr 3;93(8). pii: e02155-18. doi: 10.1128/JVI.02155-18. Print 2019 Apr 15.

18.
19.

Cost Utility of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease.

Zimmermann M, Lubinga SJ, Banken R, Rind D, Cramer G, Synnott PG, Chapman RH, Khan S, Carlson J.

Value Health. 2019 Feb;22(2):161-167. doi: 10.1016/j.jval.2018.09.2841. Epub 2018 Oct 25.

PMID:
30711060
20.

Inspiratory Muscle Training: Improvement of Exercise Performance With Acute Hypoxic Exposure.

Hursh DG, Baranauskas MN, Wiggins CC, Bielko S, Mickleborough TD, Chapman RF.

Int J Sports Physiol Perform. 2019 Jan 31:1-27. doi: 10.1123/ijspp.2018-0483. [Epub ahead of print]

PMID:
30702370
21.

Special Environments: Altitude and Heat.

Saunders PU, Garvican-Lewis LA, Chapman RF, Périard JD.

Int J Sport Nutr Exerc Metab. 2019 Mar 1;29(2):210-219. doi: 10.1123/ijsnem.2018-0256. Epub 2019 Mar 12. Review.

PMID:
30676138
22.

A single dose of fluoxetine reduces neural limbic responses to anger in depressed adolescents.

Capitão LP, Chapman R, Murphy SE, Harvey CJ, James A, Cowen PJ, Harmer CJ.

Transl Psychiatry. 2019 Jan 21;9(1):30. doi: 10.1038/s41398-018-0332-2.

23.

The NHS long term plan and public health.

Chapman R, Middleton J.

BMJ. 2019 Jan 16;364:l218. doi: 10.1136/bmj.l218. No abstract available.

PMID:
30651224
24.

Stance and swing phase knee flexion recover at different rates following total knee arthroplasty: An inertial measurement unit study.

Chapman RM, Moschetti WE, Van Citters DW.

J Biomech. 2019 Feb 14;84:129-137. doi: 10.1016/j.jbiomech.2018.12.027. Epub 2018 Dec 31.

PMID:
30630627
25.

All Wrapped up: Stabilization of Enzymes within Single Enzyme Nanoparticles.

Chapman R, Stenzel MH.

J Am Chem Soc. 2019 Feb 20;141(7):2754-2769. doi: 10.1021/jacs.8b10338. Epub 2019 Feb 11.

PMID:
30621398
26.

Assessing Upper Extremity Biomechanics during Activities of Daily Living Using Inertial Measurement Units: Does our Concept of 'Normal' Apply?

Chapman R, Torchia M, Bell JE, Van Citters D.

J Biomech Eng. 2019 Jan 7. doi: 10.1115/1.4042433. [Epub ahead of print]

PMID:
30615037
27.

Ischemic Preconditioning, O2 Kinetics, and Performance in Normoxia and Hypoxia.

Wiggins CC, Constantini K, Paris HL, Mickleborough TD, Chapman RF.

Med Sci Sports Exerc. 2019 May;51(5):900-911. doi: 10.1249/MSS.0000000000001882.

PMID:
30601792
28.

Streptococcal dTDP-L-rhamnose biosynthesis enzymes: functional characterization and lead compound identification.

van der Beek SL, Zorzoli A, Çanak E, Chapman RN, Lucas K, Meyer BH, Evangelopoulos D, de Carvalho LPS, Boons GJ, Dorfmueller HC, van Sorge NM.

Mol Microbiol. 2019 Apr;111(4):951-964. doi: 10.1111/mmi.14197. Epub 2019 Jan 31.

29.

Convergent Evidence That ZNF804A Is a Regulator of Pre-messenger RNA Processing and Gene Expression.

Chapman RM, Tinsley CL, Hill MJ, Forrest MP, Tansey KE, Pardiñas AF, Rees E, Doyle AM, Wilkinson LS, Owen MJ, O'Donovan MC, Blake DJ.

Schizophr Bull. 2018 Dec 29. doi: 10.1093/schbul/sby183. [Epub ahead of print]

PMID:
30597088
30.

Assessing the Value of Sarilumab Monotherapy for Adults with Moderately to Severely Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis.

Whittington MD, McQueen RB, Ollendorf DA, Chapman RH, Kumar VM, Synnott PG, Agboola F, Campbell JD.

J Manag Care Spec Pharm. 2019 Jan;25(1):80-87. doi: 10.18553/jmcp.2019.25.1.080. Erratum in: J Manag Care Spec Pharm. 2019 Jun;25(6):726.

31.

Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System.

Goode EC, Clark AB, Mells GF, Srivastava B, Spiess K, Gelson WTH, Trivedi PJ, Lynch KD, Castren E, Vesterhus MN, Karlsen TH, Ji SG, Anderson CA, Thorburn D, Hudson M, Heneghan MA, Aldersley MA, Bathgate A, Sandford RN, Alexander GJ, Chapman RW, Walmsley M; UK-PSC Consortium, Hirschfield GM, Rushbrook SM.

Hepatology. 2019 May;69(5):2120-2135. doi: 10.1002/hep.30479. Epub 2019 Mar 4.

32.

Limitations of current in vitro models for testing the clinical potential of epigenetic inhibitors for treatment of pediatric ependymoma.

Rogers HA, Chapman R, Kings H, Allard J, Barron-Hastings J, Pajtler KW, Sill M, Pfister S, Grundy RG.

Oncotarget. 2018 Nov 23;9(92):36530-36541. doi: 10.18632/oncotarget.26370. eCollection 2018 Nov 23.

33.

The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256.

van Diepen MT, Chapman R, Moore PL, Margolin E, Hermanus T, Morris L, Ximba P, Rybicki EP, Williamson AL.

PLoS One. 2018 Dec 17;13(12):e0208310. doi: 10.1371/journal.pone.0208310. eCollection 2018.

34.

Higher offset cross-linked polyethylene acetabular liners: is wear a significant clinical concern?

Chapman RM, Van Citters DW, Chapman D, Dalury DF.

Hip Int. 2018 Dec 7:1120700018815339. doi: 10.1177/1120700018815339. [Epub ahead of print]

PMID:
30522361
35.

Cost-Effectiveness of Targeted Pharmacotherapy for Moderate to Severe Plaque Psoriasis.

Hendrix N, Ollendorf DA, Chapman RH, Loos A, Liu S, Kumar V, Linder JA, Pearson SD, Veenstra DL.

J Manag Care Spec Pharm. 2018 Dec;24(12):1210-1217. doi: 10.18553/jmcp.2018.24.12.1210.

36.

4,6- O-Pyruvyl Ketal Modified N-Acetylmannosamine of the Secondary Cell Wall Polysaccharide of Bacillus anthracis Is the Anchoring Residue for Its Surface Layer Proteins.

Chapman RN, Liu L, Boons GJ.

J Am Chem Soc. 2018 Dec 12;140(49):17079-17085. doi: 10.1021/jacs.8b08857. Epub 2018 Nov 30.

PMID:
30452253
37.

Temporospatial components of brain ERPs as biomarkers for Alzheimer's disease.

Chapman RM, Gardner MN, Klorman R, Mapstone M, Porsteinsson AP, Antonsdottir IM, Kamalyan L.

Alzheimers Dement (Amst). 2018 Aug 30;10:604-614. doi: 10.1016/j.dadm.2018.08.002. eCollection 2018.

38.

Effect of carbohydrate ingestion on central fatigue during prolonged running exercise in moderate hypoxia.

Paris HL, Fulton TJ, Chapman RF, Fly AD, Koceja DM, Mickleborough TD.

J Appl Physiol (1985). 2019 Jan 1;126(1):141-151. doi: 10.1152/japplphysiol.00684.2018. Epub 2018 Nov 9.

PMID:
30412032
39.

Effect of inspiratory rise time on sputum movement during ventilator hyperinflation in a test lung model.

Chapman RL, Shannon H, Koutoumanou E, Main E.

Physiotherapy. 2019 Jun;105(2):283-289. doi: 10.1016/j.physio.2018.06.003. Epub 2018 Aug 8.

PMID:
30409468
40.

Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia.

Whittington MD, McQueen RB, Ollendorf DA, Kumar VM, Chapman RH, Tice JA, Pearson SD, Campbell JD.

JAMA Pediatr. 2018 Dec 1;172(12):1161-1168. doi: 10.1001/jamapediatrics.2018.2530.

PMID:
30304407
41.

Organ Donation Attitudes Among Individuals With Stage 5 Chronic Kidney Disease.

Loughery C, Andrews AM, Zhang N, Smith AH, Resnicow K, Chapman R, Riley HJ, Stav S, Yee J.

Transplant Direct. 2018 Jul 25;4(8):e378. doi: 10.1097/TXD.0000000000000818. eCollection 2018 Aug.

42.

Quantum interference of topological states of light.

Tambasco JL, Corrielli G, Chapman RJ, Crespi A, Zilberberg O, Osellame R, Peruzzo A.

Sci Adv. 2018 Sep 14;4(9):eaat3187. doi: 10.1126/sciadv.aat3187. eCollection 2018 Sep.

43.

Correction: A bodipy based hydroxylamine sensor.

Sedgwick AC, Chapman RSL, Gardiner JE, Peacock LR, Kim G, Yoon J, Bull SD, James TD.

Chem Commun (Camb). 2018 Sep 25;54(77):10922. doi: 10.1039/c8cc90409j.

PMID:
30221646
44.

Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease.

Muir AJ, Levy C, Janssen HLA, Montano-Loza AJ, Shiffman ML, Caldwell S, Luketic V, Ding D, Jia C, McColgan BJ, McHutchison JG, Mani Subramanian G, Myers RP, Manns M, Chapman R, Afdhal NH, Goodman Z, Eksteen B, Bowlus CL; GS-US-321-0102 Investigators.

Hepatology. 2019 Feb;69(2):684-698. doi: 10.1002/hep.30237. Epub 2019 Jan 11.

PMID:
30153359
45.

An engineered oilseed crop produces oil enriched in two very long chain polyunsaturated fatty acids with potential health-promoting properties.

Meesapyodsuk D, Ye S, Chen Y, Chen Y, Chapman RG, Qiu X.

Metab Eng. 2018 Sep;49:192-200. doi: 10.1016/j.ymben.2018.08.009. Epub 2018 Aug 24.

PMID:
30149205
46.

Disease-Modifying Therapies for Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Cost-Utility Analysis.

Zimmermann M, Brouwer E, Tice JA, Seidner M, Loos AM, Liu S, Chapman RH, Kumar V, Carlson JJ.

CNS Drugs. 2018 Dec;32(12):1145-1157. doi: 10.1007/s40263-018-0566-9.

PMID:
30141001
47.

Cost effectiveness of using ursodeoxycholic acid to treat primary biliary cholangitis.

Chapman RW.

Br J Hosp Med (Lond). 2018 Aug 2;79(8):460-464. doi: 10.12968/hmed.2018.79.8.460.

PMID:
30070957
48.

Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.

Zimmermann M, Rind D, Chapman R, Kumar V, Kahn S, Carlson J.

J Drugs Dermatol. 2018 Jul 1;17(7):750-756.

PMID:
30005097
49.

Non-host larvae negatively impact persistence of the entomopathogen Beauveria bassiana in soil.

Blond CLH, Ridgway HJ, Brownbridge M, Chapman RB, Condron LM, Saville DJ, Glare TR.

J Invertebr Pathol. 2018 Jul;156:19-28. doi: 10.1016/j.jip.2018.07.001. Epub 2018 Jul 9.

PMID:
30003920

Supplemental Content

Loading ...
Support Center